ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025
Respi-Radar: a tool to monitor respiratory infections, Belgium, winter season 2023/24.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the experience gained during the COVID-19 pandemic, the Belgian Risk Assessment Group (RAG) developed the Respi-Radar in the summer of 2023 to assess the epidemiological situation of respiratory infections and inform public health preparedness and response in Belgium. The Respi-Radar consists of four risk levels (green, yellow, orange and red), which indicate the extent of viral circulation and/or pressure on the healthcare system. Based on these risk levels, authorities can apply adequate measures depending on the epidemiological trends. The Respi-Radar uses six indicators from the influenza-like illness and severe acute respiratory infection sentinel surveillances in nursing homes, primary and secondary healthcare and wastewater surveillance. Additional information such as data from the national reference laboratory is also used to assess the epidemiological situation. Using the Respi-Radar tool, the RAG regularly evaluated the epidemiological situation of respiratory infections between September 2023 and March 2024. The Respi-Radar tool was useful for following epidemiological trends and effectively communicate the epidemiological situation of respiratory infections. Linking specific measures to each risk level was less straightforward. The experience gained using the Respi-Radar tool was key in determining an appropriate approach to assess and manage the epidemiological situation for future respiratory seasons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.